Analogic Corporation (NASDAQ:ALOG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers

0

Analogic Corporation (NASDAQ:ALOG) Files An 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

(b) Departure of Chief Financial Officer.

On July10, 2017, Analogic Corporation (the “Company”) informed Mark Frost of its intention to replace Mr.Frost as the Company’s Senior Vice President, Chief Financial Officer and Treasurer. On July12, 2017, the Company’s Board of Directors removed Mr.Frost from such positions, effective July13, 2017.

(c) Appointment of Chief Financial Officer.

Also on July12, 2017, the Company’s Board of Directors appointed Michael Bourque as the Company’s Senior Vice President, Chief Financial Officer and Treasurer, effective July13, 2017. In this role, Mr.Bourque will serve as the Company’s principal financial officer and will continue to serve as the Company’s principal accounting officer.

There are no family relationships between Mr.Bourque and any of the Company’s directors, executive officers or persons nominated or chosen to be directors or executive officers.

Mr.Bourque, age 54, joined the Company as its Vice President and Corporate Controller in October 2014. He also served as the Company’s Interim Chief Financial Officer and Treasurer from April through November 2015. Prior to joining the Company, he held a number of financial leadership roles in the medical and technology industries. From July 2011 to October 2014 Mr.Bourque served as Vice President and Corporate Controller of Axcelis Technologies, Inc. (“Axcelis”), a publicly traded supplier of products for the semiconductor manufacturing industry worldwide. He served as a financial consultant to Axcelis from April 2011 to July 2011. From November 2002 through October 2010, he served in a variety of finance and accounting roles, including Director of Corporate Accounting and Assistant Corporate Controller, at Charles River Laboratories, Inc., a publicly traded provider of products and services to leading pharmaceutical, biotechnology, government and academic organizations around the world. Earlier in his career, Mr.Bourque held various positions of increasing responsibility in the audit practice at Ernst& Young, LLP. Mr.Bourque, a certified public accountant, holds a Bachelor of Science degree in accountancy from Bentley University.

Other than compensation solely resulting from his employment by the Company, there have been no transactions, since the beginning of the Company’s last fiscal year, or any currently proposed transaction, in which the Company was or is to be a participant, in which Mr.Bourque had or will have a direct or indirect material interest.

On July13, 2017, the Company issued a press release announcing the departure of Mr.Frost and the appointment of Mr.Bourque as the Company’s Senior Vice President, Chief Financial Officer and Treasurer. A copy of the press release is attached hereto as Exhibit 99.1.

Item 5.02 Financial Statements and Exhibits

(d)Exhibits

ExhibitNo.

Description

99.1 Press Release dated July13, 2017


ANALOGIC CORP Exhibit
EX-99.1 2 d382896dex991.htm EX-99.1 EX-99.1 Exhibit 99.1     FOR IMMEDIATE WORLDWIDE RELEASE Investor Contact: Mark Namaroff Senior Director,…
To view the full exhibit click here

About Analogic Corporation (NASDAQ:ALOG)

Analogic Corporation designs, manufactures and commercializes guidance, diagnostic imaging and threat detection technologies. The Company operates through three segments: Medical Imaging, Ultrasound, and Security and Detection. The Company’s Medical Imaging segment provides medical imaging systems and subsystems for computed tomography (CT), magnetic resonance imaging (MRI) and high-resolution digital mammography. The Company’s Ultrasound business segment provides ultrasound procedure guidance systems for the urology and surgery markets. The Company’s Security and Detection segment designs and manufactures automated threat detection systems for aviation baggage inspection applications utilizing medical CT technology and systems used for deoxyribonucleic acid (DNA) analysis for law enforcement and government agencies.